NCT03922555 2026-04-16
ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
Massachusetts General Hospital
Phase 1 Recruiting
Clinical Trials
1 trialsPhase 1 × Central Nervous System Neoplasms × decitabine and cedazuridine drug combination × Clear all